Clinical Trial Results:
A Randomized Study of Tipifarnib Versus Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Subjects 70 Years or older.
Summary
|
|
EudraCT number |
2004-001719-77 |
Trial protocol |
HU SE DK IE DE ES SK IT GB CZ |
Global completion date |
05 Oct 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Nov 2016
|
First version publication date |
19 Nov 2016
|
Other versions |
|
Summary report(s) |
R115777-AML-301(2004-001719-77)_CSR_Synopsis (Redacted).pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.